HEADER MOTOR PROTEIN 13-MAR-08 3CJO TITLE CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 30 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KINESIN-LIKE PROTEIN KIF11; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: KINESIN-RELATED MOTOR PROTEIN EG5, KINESIN-LIKE SPINDLE COMPND 5 PROTEIN HKSP, THYROID RECEPTOR-INTERACTING PROTEIN 5, TRIP-5, COMPND 6 KINESIN-LIKE PROTEIN 1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: KIF11, EG5, KNSL1, TRIP5; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS KSP, KSP-INHIBITOR COMPLEX, ATP-BINDING, CELL CYCLE, CELL DIVISION, KEYWDS 2 COILED COIL, MICROTUBULE, MITOSIS, MOTOR PROTEIN, NUCLEOTIDE- KEYWDS 3 BINDING, PHOSPHOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.YAN REVDAT 5 30-AUG-23 3CJO 1 REMARK LINK REVDAT 4 24-FEB-09 3CJO 1 VERSN REVDAT 3 16-SEP-08 3CJO 1 JRNL REVDAT 2 08-JUL-08 3CJO 1 JRNL REVDAT 1 01-JUL-08 3CJO 0 JRNL AUTH C.D.COX,P.J.COLEMAN,M.J.BRESLIN,D.B.WHITMAN,R.M.GARBACCIO, JRNL AUTH 2 M.E.FRALEY,C.A.BUSER,E.S.WALSH,K.HAMILTON,M.D.SCHABER, JRNL AUTH 3 R.B.LOBELL,W.TAO,J.P.DAVIDE,R.E.DIEHL,M.T.ABRAMS,V.J.SOUTH, JRNL AUTH 4 H.E.HUBER,M.TORRENT,T.PRUEKSARITANONT,C.LI,D.E.SLAUGHTER, JRNL AUTH 5 E.MAHAN,C.FERNANDEZ-METZLER,Y.YAN,L.C.KUO,N.E.KOHL, JRNL AUTH 6 G.D.HARTMAN JRNL TITL KINESIN SPINDLE PROTEIN (KSP) INHIBITORS. 9. DISCOVERY OF JRNL TITL 2 (2S)-4-(2,5-DIFLUOROPHENYL)-N-[(3R,4S) JRNL TITL 3 -3-FLUORO-1-METHYLPIPERIDIN-4-YL]-2-(HYDROXYMETHYL) JRNL TITL 4 -N-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE JRNL TITL 5 (MK-0731) FOR THE TREATMENT OF TAXANE-REFRACTORY CANCER. JRNL REF J.MED.CHEM. V. 51 4239 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18578472 JRNL DOI 10.1021/JM800386Y REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.1.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.7 REMARK 3 NUMBER OF REFLECTIONS : 30723 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1527 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.74 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4978 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 21.710 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4733 REMARK 3 BIN R VALUE (WORKING SET) : 0.2134 REMARK 3 BIN FREE R VALUE : 0.2941 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.92 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 245 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 323 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.64566 REMARK 3 B22 (A**2) : 2.55525 REMARK 3 B33 (A**2) : -1.90960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5396 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 7294 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 1120 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 164 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 776 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 5396 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 118 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.31 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CJO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000046857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRROR REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 70.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 76.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.78500 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1Q0B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, POTASSIUM PHOSPHATE, PH 8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.37900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.42650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.68700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.42650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.37900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.68700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 LYS A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 GLY A 16 REMARK 465 LYS A 17 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 GLY A 276 REMARK 465 ALA A 277 REMARK 465 VAL A 278 REMARK 465 ASP A 279 REMARK 465 LYS A 280 REMARK 465 ARG A 281 REMARK 465 ALA A 282 REMARK 465 ARG A 283 REMARK 465 GLU A 284 REMARK 465 ALA A 285 REMARK 465 GLY A 286 REMARK 465 PRO A 363 REMARK 465 GLU A 364 REMARK 465 VAL A 365 REMARK 465 ASN A 366 REMARK 465 GLN A 367 REMARK 465 LYS A 368 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 PRO B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 ALA B 9 REMARK 465 LYS B 10 REMARK 465 LYS B 11 REMARK 465 LYS B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 LYS B 15 REMARK 465 GLY B 16 REMARK 465 LYS B 17 REMARK 465 ILE B 272 REMARK 465 GLY B 273 REMARK 465 ARG B 274 REMARK 465 SER B 275 REMARK 465 GLY B 276 REMARK 465 ALA B 277 REMARK 465 VAL B 278 REMARK 465 ASP B 279 REMARK 465 LYS B 280 REMARK 465 ARG B 281 REMARK 465 ALA B 282 REMARK 465 ARG B 283 REMARK 465 GLU B 284 REMARK 465 ALA B 285 REMARK 465 GLY B 286 REMARK 465 PRO B 363 REMARK 465 GLU B 364 REMARK 465 VAL B 365 REMARK 465 ASN B 366 REMARK 465 GLN B 367 REMARK 465 LYS B 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 232 O HOH B 733 2.17 REMARK 500 O HOH B 709 O HOH B 711 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 131 C - N - CD ANGL. DEV. = -13.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 36 78.51 43.65 REMARK 500 GLU A 145 -88.19 -68.19 REMARK 500 LYS A 146 -23.46 -34.72 REMARK 500 ASP A 149 -71.77 -52.59 REMARK 500 ASN A 150 167.22 -46.75 REMARK 500 PHE A 154 144.43 -176.37 REMARK 500 SER A 179 -7.26 -46.35 REMARK 500 ARG A 189 -87.85 -71.42 REMARK 500 ARG A 192 17.10 59.27 REMARK 500 ASP A 208 32.11 -83.59 REMARK 500 ARG A 305 40.12 35.47 REMARK 500 PRO A 310 40.93 -77.17 REMARK 500 ASN A 358 34.71 -94.35 REMARK 500 ASN A 361 -151.55 -130.59 REMARK 500 LEU B 30 -22.84 -36.33 REMARK 500 SER B 36 76.57 29.62 REMARK 500 ARG B 63 144.53 176.62 REMARK 500 ASP B 149 36.31 -169.84 REMARK 500 SER B 175 -73.43 -55.16 REMARK 500 ARG B 189 -81.03 -49.39 REMARK 500 ASP B 208 23.03 -75.48 REMARK 500 PRO B 310 50.91 -67.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 603 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 112 OG1 REMARK 620 2 ADP A 601 O3B 80.0 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 112 OG1 REMARK 620 2 ADP B 600 O3B 74.0 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K30 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K30 B 603 DBREF 3CJO A 2 368 UNP P52732 KIF11_HUMAN 2 368 DBREF 3CJO B 2 368 UNP P52732 KIF11_HUMAN 2 368 SEQRES 1 A 367 ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU GLU SEQRES 2 A 367 LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG PRO SEQRES 3 A 367 PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER ILE SEQRES 4 A 367 VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL ARG SEQRES 5 A 367 THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR TYR SEQRES 6 A 367 THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN ILE SEQRES 7 A 367 ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP GLU SEQRES 8 A 367 VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR GLY SEQRES 9 A 367 GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY GLU SEQRES 10 A 367 ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP PRO SEQRES 11 A 367 LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE PHE SEQRES 12 A 367 GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL LYS SEQRES 13 A 367 VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE ASP SEQRES 14 A 367 LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU GLN SEQRES 15 A 367 MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE ILE SEQRES 16 A 367 LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP GLU SEQRES 17 A 367 VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG THR SEQRES 18 A 367 THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SER SEQRES 19 A 367 HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU THR SEQRES 20 A 367 THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS LEU SEQRES 21 A 367 ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY ARG SEQRES 22 A 367 SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY ASN SEQRES 23 A 367 ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE THR SEQRES 24 A 367 ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG GLU SEQRES 25 A 367 SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY GLY SEQRES 26 A 367 ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO ALA SEQRES 27 A 367 SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU TYR SEQRES 28 A 367 ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU VAL SEQRES 29 A 367 ASN GLN LYS SEQRES 1 B 367 ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU GLU SEQRES 2 B 367 LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG PRO SEQRES 3 B 367 PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER ILE SEQRES 4 B 367 VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL ARG SEQRES 5 B 367 THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR TYR SEQRES 6 B 367 THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN ILE SEQRES 7 B 367 ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP GLU SEQRES 8 B 367 VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR GLY SEQRES 9 B 367 GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY GLU SEQRES 10 B 367 ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP PRO SEQRES 11 B 367 LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE PHE SEQRES 12 B 367 GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL LYS SEQRES 13 B 367 VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE ASP SEQRES 14 B 367 LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU GLN SEQRES 15 B 367 MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE ILE SEQRES 16 B 367 LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP GLU SEQRES 17 B 367 VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG THR SEQRES 18 B 367 THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SER SEQRES 19 B 367 HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU THR SEQRES 20 B 367 THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS LEU SEQRES 21 B 367 ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY ARG SEQRES 22 B 367 SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY ASN SEQRES 23 B 367 ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE THR SEQRES 24 B 367 ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG GLU SEQRES 25 B 367 SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY GLY SEQRES 26 B 367 ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO ALA SEQRES 27 B 367 SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU TYR SEQRES 28 B 367 ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU VAL SEQRES 29 B 367 ASN GLN LYS HET MG A 603 1 HET ADP A 601 27 HET K30 A 1 33 HET MG B 602 1 HET ADP B 600 27 HET K30 B 603 33 HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM K30 (2S)-4-(2,5-DIFLUOROPHENYL)-N-[(3R,4S)-3-FLUORO-1- HETNAM 2 K30 METHYLPIPERIDIN-4-YL]-2-(HYDROXYMETHYL)-N-METHYL-2- HETNAM 3 K30 PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE FORMUL 3 MG 2(MG 2+) FORMUL 4 ADP 2(C10 H15 N5 O10 P2) FORMUL 5 K30 2(C25 H28 F3 N3 O2) FORMUL 9 HOH *323(H2 O) HELIX 1 1 ASN A 29 LYS A 34 1 6 HELIX 2 2 LYS A 77 VAL A 85 1 9 HELIX 3 3 VAL A 85 ILE A 94 1 10 HELIX 4 4 GLY A 110 GLU A 116 1 7 HELIX 5 5 GLY A 134 ASP A 149 1 16 HELIX 6 6 ASN A 206 ASP A 208 5 3 HELIX 7 7 GLU A 209 MET A 228 1 20 HELIX 8 8 ALA A 230 SER A 235 1 6 HELIX 9 9 ASN A 289 GLU A 304 1 16 HELIX 10 10 PRO A 310 GLU A 313 5 4 HELIX 11 11 SER A 314 LEU A 320 1 7 HELIX 12 12 GLN A 321 LEU A 324 5 4 HELIX 13 13 ALA A 339 LEU A 341 5 3 HELIX 14 14 ASN A 342 ALA A 356 1 15 HELIX 15 15 LYS A 357 ILE A 359 5 3 HELIX 16 16 LYS B 77 VAL B 85 1 9 HELIX 17 17 VAL B 85 MET B 95 1 11 HELIX 18 18 GLY B 110 GLU B 116 1 7 HELIX 19 19 SER B 120 GLU B 124 5 5 HELIX 20 20 THR B 126 ASP B 130 5 5 HELIX 21 21 GLY B 134 LEU B 147 1 14 HELIX 22 22 ASN B 206 ASP B 208 5 3 HELIX 23 23 GLU B 209 MET B 228 1 20 HELIX 24 24 ALA B 230 SER B 235 1 6 HELIX 25 25 ASN B 289 GLU B 304 1 16 HELIX 26 26 PRO B 310 GLU B 313 5 4 HELIX 27 27 SER B 314 LEU B 320 1 7 HELIX 28 28 GLN B 321 LEU B 324 5 4 HELIX 29 29 ASN B 342 LYS B 357 1 16 SHEET 1 A 8 MET A 70 PHE A 72 0 SHEET 2 A 8 GLN A 20 CYS A 25 1 N CYS A 25 O PHE A 72 SHEET 3 A 8 ARG A 329 ILE A 336 1 O ALA A 334 N ARG A 24 SHEET 4 A 8 ASN A 98 GLY A 105 1 N PHE A 102 O ILE A 333 SHEET 5 A 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 A 8 HIS A 236 THR A 248 -1 N ILE A 243 O GLY A 259 SHEET 7 A 8 THR A 152 TYR A 164 -1 N LEU A 161 O VAL A 238 SHEET 8 A 8 GLU A 167 ASP A 170 -1 O PHE A 169 N GLU A 162 SHEET 1 B 8 MET A 70 PHE A 72 0 SHEET 2 B 8 GLN A 20 CYS A 25 1 N CYS A 25 O PHE A 72 SHEET 3 B 8 ARG A 329 ILE A 336 1 O ALA A 334 N ARG A 24 SHEET 4 B 8 ASN A 98 GLY A 105 1 N PHE A 102 O ILE A 333 SHEET 5 B 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 B 8 HIS A 236 THR A 248 -1 N ILE A 243 O GLY A 259 SHEET 7 B 8 THR A 152 TYR A 164 -1 N LEU A 161 O VAL A 238 SHEET 8 B 8 ILE A 202 THR A 203 -1 O ILE A 202 N VAL A 158 SHEET 1 C 3 VAL A 41 ASP A 44 0 SHEET 2 C 3 GLU A 49 GLY A 56 -1 O GLU A 49 N ASP A 44 SHEET 3 C 3 SER A 61 THR A 67 -1 O LYS A 64 N VAL A 52 SHEET 1 D 2 GLN A 183 ASP A 186 0 SHEET 2 D 2 VAL A 194 LYS A 197 -1 O ILE A 195 N PHE A 185 SHEET 1 E 8 MET B 70 PHE B 72 0 SHEET 2 E 8 GLN B 20 CYS B 25 1 N VAL B 23 O PHE B 72 SHEET 3 E 8 ARG B 329 ILE B 336 1 O ALA B 334 N VAL B 22 SHEET 4 E 8 ASN B 98 GLY B 105 1 N PHE B 102 O ILE B 333 SHEET 5 E 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 E 8 HIS B 236 THR B 248 -1 N GLU B 247 O LEU B 255 SHEET 7 E 8 THR B 152 TYR B 164 -1 N GLU B 153 O LYS B 246 SHEET 8 E 8 GLU B 167 ASP B 170 -1 O PHE B 169 N GLU B 162 SHEET 1 F 8 MET B 70 PHE B 72 0 SHEET 2 F 8 GLN B 20 CYS B 25 1 N VAL B 23 O PHE B 72 SHEET 3 F 8 ARG B 329 ILE B 336 1 O ALA B 334 N VAL B 22 SHEET 4 F 8 ASN B 98 GLY B 105 1 N PHE B 102 O ILE B 333 SHEET 5 F 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 F 8 HIS B 236 THR B 248 -1 N GLU B 247 O LEU B 255 SHEET 7 F 8 THR B 152 TYR B 164 -1 N GLU B 153 O LYS B 246 SHEET 8 F 8 ILE B 202 VAL B 204 -1 O VAL B 204 N VAL B 156 SHEET 1 G 3 VAL B 41 ASP B 44 0 SHEET 2 G 3 GLU B 49 GLY B 56 -1 O GLU B 49 N ASP B 44 SHEET 3 G 3 SER B 61 THR B 67 -1 O LYS B 64 N VAL B 52 SHEET 1 H 2 GLN B 183 ASP B 186 0 SHEET 2 H 2 VAL B 194 LYS B 197 -1 O ILE B 195 N PHE B 185 LINK OG1 THR A 112 MG MG A 603 1555 1555 2.08 LINK O3B ADP A 601 MG MG A 603 1555 1555 2.10 LINK OG1 THR B 112 MG MG B 602 1555 1555 1.95 LINK O3B ADP B 600 MG MG B 602 1555 1555 2.44 SITE 1 AC1 1 THR B 112 SITE 1 AC2 1 THR A 112 SITE 1 AC3 12 ARG A 24 ARG A 26 PRO A 27 GLN A 106 SITE 2 AC3 12 THR A 107 GLY A 108 THR A 109 GLY A 110 SITE 3 AC3 12 LYS A 111 THR A 112 PHE A 113 GLU A 118 SITE 1 AC4 11 ARG B 26 PRO B 27 GLN B 106 THR B 107 SITE 2 AC4 11 GLY B 108 THR B 109 GLY B 110 LYS B 111 SITE 3 AC4 11 THR B 112 PHE B 113 GLU B 118 SITE 1 AC5 14 GLU A 116 GLY A 117 GLU A 118 ARG A 119 SITE 2 AC5 14 ALA A 133 ILE A 136 PRO A 137 LEU A 160 SITE 3 AC5 14 TYR A 211 LEU A 214 GLU A 215 GLY A 217 SITE 4 AC5 14 ALA A 218 ARG A 221 SITE 1 AC6 12 GLU B 116 GLY B 117 GLU B 118 ARG B 119 SITE 2 AC6 12 TRP B 127 ALA B 133 PRO B 137 TYR B 211 SITE 3 AC6 12 LEU B 214 GLU B 215 GLY B 217 ALA B 218 CRYST1 68.758 79.374 158.853 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014544 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012599 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006295 0.00000